The recent Viral Manufacturing and Translational Consortium (VMTC) held at The Hormel Institute, University of Minnesota, showcased the latest innovations in viral vector manufacturing. Bringing together experts from academia and industry, the event highlighted cutting-edge techniques and technologies being utilized to improve the production of viral vectors for various applications including gene therapy, vaccine development, and more. With a focus on enhancing efficiency, scalability, and safety in manufacturing processes, the consortium aimed to foster collaborations and drive progress in the field. Attendees gained valuable insights into emerging trends and best practices, paving the way for future advancements in viral vector production. Stay tuned for updates on the groundbreaking research and developments in this rapidly evolving area of biotechnology.
Read more about this — here
